Immunotherapy for Third Line Metastatic Colorectal Cancer

ABSTRACT: This is a Phase IIB multi-site, open label study of a next generation immunotherapy for third-line MSI-S metastatic colorectal cancer using an "off-the-shelf", non-genetically manipulated living immune cell product (AlloStim) derived from the blood of healthy donors.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2343551 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR